title: [Effect of long-term prazosin treatment on certain humoral and metabolic factors in patients with primary hypertension].
abstract: An effect of the long-term prazosin therapy on sympathetic activity, renin plasma activity and beta-endorphin and lipid blood levels was investigated in 23 patients with the primary arterial blood hypertension. Group A included 18 patients treated with prazosin, and group B - 5 patients treated with prazosin combined with propranolol. Mean daily dose of prazosin in group A was 3.0-10.0 +/- 1.3 mg in different phases of therapy whereas in group B mean daily dose of prazosin was 3.0-6.5 +/- 1.8 mg and propranolol 50-80 mg. Significant decrease in diastolic and systolic blood pressure (p < 0.01) was achieved in both groups. Additionally significant decrease in pulse rate (p < 0.01) was seen in group B. It was found that prazosin produced significant increase in plasma noradrenaline in group A and decrease in 4-hydroxy-3-methoxyglycol excretion with the urine (p < 0.05) in both groups. Moreover, negative correlation between a decrease in blood pressure (diastolic) and noradrenaline excretion with the urine (p < 0.05) was noted in group A. No effect of prazosin therapy on plasma renin activity, beta-endorphin and lipids blood levels was observed in both groups. These results suggest that prazosin therapy in patients with the primary blood hypertension exerts an effect on sympathetic activity and does not change plasma renin activity or blood beta-endorphin and lipids levels.
authors.affiliation: Kliniki Nadciśnienia Tetniczego i Chorób Naczyń Instytutu Chorób Wewnetrznych AM, Warszawie.
authors.forename: K
authors.initials: K
authors.lastname: Knypl
authors.forename: E
authors.initials: E
authors.lastname: Brym
authors.forename: E
authors.initials: E
authors.lastname: Czerniewska
authors.forename: B
authors.initials: B
authors.lastname: Wocial
authors.forename: K
authors.initials: K
authors.lastname: Kuczyńska
authors.forename: J
authors.initials: J
authors.lastname: Chodakowska
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D011224:Prazosin / Q000627:therapeutic use*; D012083:Renin / Q000097:blood; D013564:Sympathetic Nervous System / Q000187:drug effects; D001615:beta-Endorphin / Q000097:blood
chemical_list: D008055:Lipids; D001615:beta-Endorphin; D012083:Renin; D009638:Norepinephrine; D011224:Prazosin
vernacular_title: Wpływ długotrwałego leczenia prazosyna na niektóre wskaźniki humoralne i metaboliczne u chorych na nadciśnienie tetnicze pierwotne.